Additional file 2: Figure S1. Distribution and prognostic value of PMT scores in gliomas from multiple datasets. Figure S2. Influence of PMT score on responses to chemotherapy or radiotherapy. Figure S3. Evaluation of the distribution of glioma cases in a scale-free network. Figure S4. Associations between the PMT-related risk signature and other features in TCGA and CGGA datasets. Figure S5. The predictive value of the risk signature on survival was verified in high-grade cases from the CGGA. Figure S6. Functional enrichment of the risk signature was verified in the CGGA. Figure S7. Correlations between immunosuppressive status and the risk signature in GBM. Figure S8. Construction of the PMT-related lncRNA/miRNA/mRNA (ceRNA) network in GBM. Figure S9. The effect of LINC01503 on PMT in glioma cell.
